Emergent BioSolutions traded at $31.83 this Friday July 1st, increasing $0.79 or 2.55 percent since the previous trading session. Looking back, over the last four weeks, Emergent BioSolutions gained 2.87 percent. Over the last 12 months, its price fell by 50.08 percent. Looking ahead, we forecast Emergent BioSolutions to be priced at 31.88 by the end of this quarter and at 29.37 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
31.83
Daily Change
2.55%
Yearly
-50.08%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 14.37 0.28 1.99% -40.86%
Akebia Therapeutics 0.39 0.04 10.17% -89.51%
ALKERMES 30.53 0.74 2.48% 20.67%
Alnylam Pharmaceuticals 148.25 2.40 1.65% -13.52%
Amarin 1.44 -0.05 -3.36% -67.20%
ANI Pharmaceuticals 31.54 1.87 6.29% -10.00%
BioMarin Pharmaceutical 84.98 2.11 2.55% -0.57%
Coherus Biosciences 7.83 0.59 8.15% -42.97%
Chimerix 2.14 0.06 2.88% -74.31%
Emergent BioSolutions 31.83 0.79 2.55% -50.08%
Exact Sciences 41.13 1.74 4.42% -66.51%
Exelixis 21.57 0.75 3.60% 18.13%
Glaxosmithkline 43.75 0.22 0.51% 8.27%
Heron Therapeutics 2.72 -0.07 -2.51% -81.71%
Intercept Pharmaceuticals 14.13 0.32 2.32% -29.31%
Immunogen 4.61 0.11 2.44% -28.30%
Ionis Pharmaceuticals 38.06 1.04 2.81% -4.66%
Ironwood Pharmaceuticals 11.53 0 0% -8.35%
Jazz Pharmaceuticals 158.58 2.57 1.65% -12.63%
Lonza Group 519.20 10.20 2.00% -20.78%
Lexicon Pharmaceuticals 1.94 0.08 4.30% -52.91%
Merck & Co 92.42 1.25 1.37% 17.58%
Moderna Inc 149.95 7.10 4.97% -36.00%
Myriad Genetics 18.63 0.46 2.53% -40.48%
Neurocrine Biosciences 99.25 1.77 1.82% 0.65%
Nektar Therapeutics 3.75 -0.05 -1.32% -78.08%
Opko Health 2.63 0.10 3.95% -34.41%
Pacira 57.85 -0.45 -0.77% -2.41%
Pfizer 52.31 -0.12 -0.23% 31.66%
PTC Therapeutics 41.85 1.79 4.47% -2.88%
Sanofi 97.52 1.18 1.22% 10.94%
Seattle Genetics 180.11 3.17 1.79% 14.52%
Sarepta Therapeutics 75.71 0.75 1.00% 0.62%
Teva Pharmaceutical Industries 7.89 0.37 4.92% -19.74%
United Therapeutics 238.00 2.36 1.00% 29.12%
Vanda Pharmaceuticals 11.19 0.29 2.66% -46.25%
Xoma 20.84 -1.44 -6.46% -37.42%

Indexes Price Day Year
US2000 1728 19.77 1.16% -25.07%
US400 2296 26.97 1.19% -15.27%

Emergent BioSolutions
Emergent BioSolutions Inc. is a life sciences company focused on providing civilian and military populations with a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). The Company is focused on five PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE); emerging infectious diseases (EID); travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). It operates through four business units, which includes three product business units: Vaccines, Devices, Therapeutics; and one services business unit: CDMO. The Company's contract development and manufacturing service offerings cover development services, drug substance manufacturing and drug product manufacturing across the pharmaceutical and biotechnology industries as well as the United States Government (USG) and non-Governmental organizations.